Cerevel Therapeutics Holdings Inc (DELISTED) (CERE:DL)
44.96
0.00 (0.00%)
USD |
NASDAQ |
Aug 01, 16:00
Cerevel Therapeutics Holdings 1 Year Total Returns (Daily): 46.69% for Aug. 1, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| August 01, 2024 | 46.69% |
| July 31, 2024 | 46.98% |
| July 30, 2024 | 46.47% |
| July 29, 2024 | 45.75% |
| July 26, 2024 | 49.03% |
| July 25, 2024 | 44.48% |
| July 24, 2024 | 41.59% |
| July 23, 2024 | 47.17% |
| July 22, 2024 | 47.30% |
| July 19, 2024 | 47.37% |
| July 18, 2024 | 45.93% |
| July 17, 2024 | 43.94% |
| July 16, 2024 | 40.66% |
| July 15, 2024 | 38.83% |
| July 12, 2024 | 32.60% |
| July 11, 2024 | 35.93% |
| July 10, 2024 | 33.80% |
| July 09, 2024 | 34.38% |
| July 08, 2024 | 34.58% |
| July 05, 2024 | 28.36% |
| July 03, 2024 | 28.14% |
| July 02, 2024 | 29.69% |
| July 01, 2024 | 30.07% |
| June 28, 2024 | 25.54% |
| June 27, 2024 | 23.97% |
| Date | Value |
|---|---|
| June 26, 2024 | 20.17% |
| June 25, 2024 | 22.25% |
| June 24, 2024 | 28.00% |
| June 21, 2024 | 25.94% |
| June 20, 2024 | 21.98% |
| June 18, 2024 | 23.05% |
| June 17, 2024 | 21.93% |
| June 14, 2024 | 21.55% |
| June 13, 2024 | 21.43% |
| June 12, 2024 | 25.46% |
| June 11, 2024 | 22.69% |
| June 10, 2024 | 22.66% |
| June 07, 2024 | 22.76% |
| June 06, 2024 | 21.82% |
| June 05, 2024 | 24.73% |
| June 04, 2024 | 21.78% |
| June 03, 2024 | 21.72% |
| May 31, 2024 | 24.97% |
| May 30, 2024 | 24.89% |
| May 29, 2024 | 22.22% |
| May 28, 2024 | 22.75% |
| May 24, 2024 | 24.90% |
| May 23, 2024 | 25.13% |
| May 22, 2024 | 22.50% |
| May 21, 2024 | 28.68% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-46.91%
Minimum
Aug 10 2023
354.3%
Maximum
Nov 05 2021
50.98%
Average
29.42%
Median
1 Year Total Returns (Daily) Benchmarks
| AbbVie Inc | 27.41% |
| Amgen Inc | 16.44% |
| Biogen Inc | -25.52% |
| Gilead Sciences Inc | 28.73% |
| Eli Lilly and Co | 33.37% |